These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38973526)

  • 1. Assessment of the clinical value of five noninvasive predictors of metabolic dysfunction-associated steatotic liver disease in Han Chinese adults.
    Ma X; Zou H; Zhan J; Gao J; Xie Y
    Eur J Gastroenterol Hepatol; 2024 Oct; 36(10):1209-1219. PubMed ID: 38973526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease.
    Colantoni A; Bucci T; Cocomello N; Angelico F; Ettorre E; Pastori D; Lip GYH; Del Ben M; Baratta F
    Cardiovasc Diabetol; 2024 May; 23(1):175. PubMed ID: 38769519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease.
    Chen Q; Hu P; Hou X; Sun Y; Jiao M; Peng L; Dai Z; Yin X; Liu R; Li Y; Zhu C
    Cardiovasc Diabetol; 2024 Jul; 23(1):232. PubMed ID: 38965572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease.
    Min Y; Wei X; Wei Z; Song G; Zhao X; Lei Y
    Cardiovasc Diabetol; 2024 Jun; 23(1):188. PubMed ID: 38824550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort.
    Priego-Parra BA; Reyes-Diaz SA; Ordaz-Alvarez HR; Bernal-Reyes R; Icaza-Chávez ME; Martínez-Vázquez SE; Amieva-Balmori M; Vivanco-Cid H; Velasco JAV; Gracia-Sancho J; Remes-Troche JM
    Clin Res Hepatol Gastroenterol; 2024 Aug; 48(7):102400. PubMed ID: 38901566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.
    Guo Y; Hu Y; Yang J; Ma R; Zhang X; Guo H; Wang X; Li Y; Peng X; Zhang S; He J; Guo S
    Eur J Med Res; 2023 Dec; 28(1):555. PubMed ID: 38042816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
    Li L; You W; Ren W
    Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population.
    Zhang L; Zhang M; Wang M; Wang M; Zhang R; Wang H; Zhang W; Ding Y; Wang J
    Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):865-872. PubMed ID: 35802528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting metabolic syndrome by obesity- and lipid-related indices in mid-aged and elderly Chinese: a population-based cross-sectional study.
    Li Y; Gui J; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L
    Front Endocrinol (Lausanne); 2023; 14():1201132. PubMed ID: 37576971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty Liver Index (FLI) is the best score to predict MASLD with 50% lower cut-off value in women than in men.
    Crudele L; De Matteis C; Novielli F; Di Buduo E; Petruzzelli S; De Giorgi A; Antonica G; Berardi E; Moschetta A
    Biol Sex Differ; 2024 May; 15(1):43. PubMed ID: 38760802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal obesity- and lipid-related indices for predicting type 2 diabetes in middle-aged and elderly Chinese.
    Zhang X; Wang Y; Li Y; Gui J; Mei Y; Yang X; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Li J; Liu M; Hua Y; Zhang L
    Sci Rep; 2024 May; 14(1):10901. PubMed ID: 38740846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the predictive power of adiposity indices and blood lipid indices for diagnosis of prediabetes.
    Zhang Y; Wang M; Zuo Y; Su X; Wen J; Zhai Q; He Y
    Hormones (Athens); 2022 Dec; 21(4):683-690. PubMed ID: 36166170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between serum ferritin baselines and trajectories and the incidence of metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.
    Song Z; Miao X; Xie X; Tang G; Deng J; Hu M; Liu S; Leng S
    Lipids Health Dis; 2024 May; 23(1):141. PubMed ID: 38760825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort.
    Oh JH; Ahn SB; Cho S; Nah EH; Yoon EL; Jun DW
    J Hepatol; 2024 Nov; 81(5):772-780. PubMed ID: 38879175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of four surrogate indexes of insulin resistance in middle-aged population in Hefei, China.
    Huang R; Cheng Z; Jin X; Yu X; Yu J; Guo Y; Zong L; Sheng J; Liu X; Wang S
    Ann Med; 2022 Dec; 54(1):622-632. PubMed ID: 35175162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Clínica Universidad de Navarra-Body Adiposity Estimator index is a reliable tool for screening metabolic dysfunction-associated steatotic liver disease: an analysis from a gender perspective.
    Wang C; Huang X; He S; Kuang M; Xie G; Sheng G; Zou Y
    Lipids Health Dis; 2024 Sep; 23(1):311. PubMed ID: 39334354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FibroScan-aspartate transaminase: A superior non-invasive model for diagnosing high-risk metabolic dysfunction-associated steatohepatitis.
    Yin JY; Yang TY; Yang BQ; Hou CX; Li JN; Li Y; Wang Q
    World J Gastroenterol; 2024 May; 30(18):2440-2453. PubMed ID: 38764767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting hypertension by obesity- and lipid-related indices in mid-aged and elderly Chinese: a nationwide cohort study from the China Health and Retirement Longitudinal Study.
    Li Y; Gui J; Zhang X; Wang Y; Mei Y; Yang X; Liu H; Guo LL; Li J; Lei Y; Li X; Sun L; Yang L; Yuan T; Wang C; Zhang D; Wei H; Li J; Liu M; Hua Y; Zhang L
    BMC Cardiovasc Disord; 2023 Apr; 23(1):201. PubMed ID: 37081416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.